| US 7,585,514 B2 | ||
| Administration of agents mimicking DOPAchrome tautomerase (TRP-2) activity for protecting hair follicle melanocytes | ||
| Stephane Commo, Paris (France); Olivier Gaillard, Forges-les-Bains (France); and Bruno Bernard, Neuilly sur Siene (France) | ||
| Assigned to L'Oreal, Paris (France) | ||
| Filed on Dec. 13, 2004, as Appl. No. 11/9,153. | ||
| Application 11/009153 is a continuation of application No. PCT/FR03/01729, filed on Jun. 10, 2003. | ||
| Claims priority of application No. 02/07137 (FR), filed on Jun. 11, 2002. | ||
| Prior Publication US 2005/0186233 A1, Aug. 25, 2005 | ||
| Int. Cl. A61K 8/02 (2006.01) | ||
| U.S. Cl. 424—401 | 1 Claim |
| 1. A regime or regimen for preventing and/or limiting and/or arresting the development of canities, comprising:
administering to an individual in need of such treatment, for such period of time as required to elicit the desired effect,
a thus effective amount of an active agent mimicking DOPAchrome tautomerase activity, wherein the active agent mimicking DOPAchrome
tautomerase activity is a salen-manganese complex.
|